This month's main topic: This Holiday Season, Keep Children Safe from Accidental Medication Poisonings
ISMP Medication Safety Alert!®
Community/Ambulatory
A valuable resource to reduce medication error risk in outpatient settings
The ISMP Medication Safety Alert!®Community/Ambulatory Care is a digital newsletter, published monthly for healthcare practitioners in ambulatory settings, including community pharmacies, specialty pharmacies, outpatient clinics, physician offices, and state institutions.
Who reads this newsletter?
- Community/ambulatory/specialty care pharmacists
- Pharmacy managers and executives
- Pharmacy technicians and other pharmacy staff
- Physicians and nurses in ambulatory practice
- Anyone concerned with medication safety
Related
Subscription Options
Online access to twelve (12) issues per year. You will receive a reminder notice via email to renew your annual subscription before your subscription expires. Your subscription will not automatically renew.
Single issues are available for purchase.
Academic-based subscription: contact ISMP for pricing
Pharmaceutical Industry (and other healthcare related companies): contact ISMP for pricing
Chain Pharmacies & Multi Site organizations: contact ISMP for pricing
Personal Subscription
Subscription Information
-
$72.00 per year
-
Online access for one (1) user
-
No redistribution is permitted
Single Site Subscription
Subscription Information for healthcare organizations (e.g. hospitals, clinics, pharmacies)
-
$105.00 per year
-
Online access for up to 50 users within a single site organization
-
Permission to redistribute within single-site location
-
Instructions to add users to a subscription will be emailed to the user purchasing the subscription
-
Please use your organization email address when subscribing
-
Chain pharmacies/Multi-site organizations: Contact ISMP for pricing
Browse Issues
Community/Ambulatory
VOLUME 14, ISSUE 10
This month's main topic: Severe Harm and Death Associated with Medication Errors and Drug-Drug Interactions Involving Low-Dose Methotrexate
Community/Ambulatory
VOLUME 14, ISSUE 9
This month's main topic: QuarterWatch™ 2014 Annual Report: Signals for TNF Blocking Agents, Anticoagulants, Lipitor, Growth Hormone
Community/Ambulatory
Problem: Pharmacists and veterinarians should be aware of the potential for animal injury due to confusion between human drugs and animal drugs that have lookalike or sound-alike names. The US Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) has recently received a report of a dog mistakenly receiving the human drug SINEQUAN (doxepin) instead of the prescribed animal drug ZENIQUIN (marbofloxacin). The dog became ill (lethargy, anorexia, and oliguria) 24 hours after being administered the SINEquan. Fortunately, the dog was treated and recovered.
Drug name confusions...
Community/Ambulatory
VOLUME 14, ISSUE 8
This month's main topic: Draft Guidelines for the Safe Communication of Electronic Medication Information
Community/Ambulatory
VOLUME 14, ISSUE 7
The month's main topic: Open the Bag to Catch Errors at the Point-of-Sale
Community/Ambulatory
VOLUME 14, ISSUE 6
This month's main topic: One Choice too Many…Time to Eliminate Teaspoonful
Community/Ambulatory
VOLUME 14, ISSUE 5
This month's main topic: QuarterWatch™ 2014 Quarter 2: Zolpidem and Canagliflozin Safety Signals, Thousands of Incomplete Rosiglitazone Reports
Community/Ambulatory
VOLUME 14, ISSUE 4
This month's main topic: Life-Threatening Error with Flecainide Suspension in Children
Community/Ambulatory
VOLUME 14, ISSUE 3
This month's main topic: Recommendations for Practitioners to Prevent Vaccine Errors. Part 2: Analysis of ISMP Vaccine Errors Reporting Program (ISMP VERP)
Community/Ambulatory
VOLUME 14, ISSUE 2
This month's main topic: Misidentification of Alphanumeric Symbols
Community/Ambulatory
VOLUME 14, ISSUE 1
This month's main topic: QuarterWatch (Speical Report): A Critique of FDA’s Key Drug Safety Reporting Program